# Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases

> **NCT05027711** · PHASE2 · RECRUITING · sponsor: **University Hospital Heidelberg** · enrollment: 90 (estimated)

## Conditions studied

- Hepatic Metastasis

## Interventions

- **RADIATION:** ITV (Internal target volume)-based Stereotactic Body Radiotherapy (ITV-SBRT)
- **RADIATION:** MRgSBRT (Magnetic Resonance-guided Stereotactic Body Radiotherapy)

## Key facts

- **NCT ID:** NCT05027711
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-08-12
- **Primary completion:** 2029-01-31
- **Final completion:** 2030-01-31
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027711, "Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05027711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*